Globenewswire.com ELMWOOD PARK, N.J., April 30, 2026 (GLOBE NEWSWIRE) — BioReference® Health LLC, an OPKO Health, Inc. company and a trusted provider of diagnostic testing in the United States, today announced the launch of BioReference DirectTM, a new digital health platform designed to give consumers direct access to high-quality laboratory testing. Leveraging 45 years of […]
Search Results for: FORM
Blog
The Power of Data Integration: Transforming Oncology Outcomes with Clinical and Genomic Insights
07
Dec
Dec
In the world of healthcare, data has become essential to driving better patient outcomes. From clinical records to genomic insights, the convergence of various data sources is revolutionizing research and development (R&D) in pharmaceutical companies. In this article, we will explore the remarkable potential of real-world data (RWD), particularly in oncology, and how its integration […]
Press Release
Aspira Women’s Health Announces Formal Launch of Co-Marketing and Distribution Collaboration with BioReference
05
Oct
Oct
Aspira Women’s Health Inc. OVA1Plus® now available to an expanded network of physicians, supporting patients nationwide AUSTIN, Texas, Oct. 05, 2022 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the formal launch of its co-marketing and distribution collaboration with BioReference®, an OPKO Health […]
The Spokesman-Review Local health sciences company Gestalt Diagnostics says it has achieved a significant milestone by using artificial intelligence and digital pathology to improve patient care. BioReference Laboratories, an OPKO Health company that serves more than 19 million patients per year, has adopted Gestalt Diagnostics’ digital pathology platform in combination with an algorithm developed by […]
Press Release
BioReference Laboratories Forms a Strategic Collaboration with SOMOS to Improve Health Outcomes of Underserved New Yorkers
01
Jul
Jul
BioReference to also assist with Patient-Centered Data Analytics to SOMOS Providers SOMOS, New York City’s Largest Multi-Cultural Physician-Led Network Selects BioReference as Preferred Provider for Diagnostic Testing MIAMI, FL., July 01, 2019 (GLOBE NEWSWIRE) — BioReference Laboratories, Inc., an OPKO Health (NASDAQ: OPK) company and one of the largest clinical laboratories in the United States, has been selected […]
Log in to view your latest lab test results, check your balance, and manage your insurance information.
30
Oct
Oct
Careers Join us in transforming the future of healthcare through innovation and excellence.
